These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36277664)

  • 1. The Coronary Sinus Reducer - Clinical Evidence and New Perspectives On An Emerging Tool in the Treatment of Refractory Angina.
    Zivelonghi C; Verheye S
    Heart Int; 2020; 14(1):29-33. PubMed ID: 36277664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience.
    Abawi M; Nijhoff F; Stella PR; Voskuil M; Benedetto D; Doevendans PA; Agostoni P
    Neth Heart J; 2016 Sep; 24(9):544-51. PubMed ID: 27299456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina: A Single-Center Experience.
    Giannini F; Baldetti L; Ponticelli F; Ruparelia N; Mitomo S; Latib A; Montorfano M; Jabbour RJ; Aurelio A; Ferri L; Mangieri A; Regazzoli D; Ancona M; Pagnesi M; Faccini A; Chieffo A; Azzalini L; Carlino M; Colombo A
    JACC Cardiovasc Interv; 2018 Apr; 11(8):784-792. PubMed ID: 29673511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary sinus reducer for the treatment of chronic refractory angina pectoris.
    Ponticelli F; Giannini F
    Future Cardiol; 2022 Jul; 18(7):523-537. PubMed ID: 35758146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary Sinus Reducer for the Treatment of Chronic Refractory Angina: Will This Challenge the Treatment of Coronary Chronic Total Occlusions?
    Vescovo GM; Zivelonghi C; Bellamoli M; Vermeersch P; Verheye S; Agostoni P
    Curr Cardiol Rep; 2021 Mar; 23(4):31. PubMed ID: 33655425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study.
    Banai S; Ben Muvhar S; Parikh KH; Medina A; Sievert H; Seth A; Tsehori J; Paz Y; Sheinfeld A; Keren G
    J Am Coll Cardiol; 2007 May; 49(17):1783-9. PubMed ID: 17466229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of coronary sinus reducer in patients with refractory angina-A systematic review of the literature.
    Bazoukis G; Brilakis ES; Tse G; Letsas KP; Kitsoulis P; Liu T; Baranchuk A; Sideris A; Tsioufis C; Stavrakis S
    J Interv Cardiol; 2018 Dec; 31(6):775-779. PubMed ID: 30191622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial.
    Jolicœur EM; Banai S; Henry TD; Schwartz M; Doucet S; White CJ; Edelman E; Verheye S
    Trials; 2013 Feb; 14():46. PubMed ID: 23413981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Sinus Reducer implantation improves symptoms, ischaemia and physical capacity in patients with refractory angina unsuitable for myocardial revascularisation: a single-centre experience.
    Konigstein M; Bazan S; Revivo M; Banai S
    EuroIntervention; 2018 Jul; 14(4):e452-e458. PubMed ID: 29688178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary Sinus Reducer implantation: a new treatment for chronic refractory angina].
    Giannini F; Aurelio A; Chieffo A
    G Ital Cardiol (Rome); 2016 Oct; 17(10 Suppl 1):3S-9. PubMed ID: 27729662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantation of the coronary sinus reducer for refractory angina due to coronary microvascular dysfunction in the context of apical hypertrophic cardiomyopathy-a case report.
    Cheng K; Keramida G; Baksi AJ; de Silva R
    Eur Heart J Case Rep; 2022 Nov; 6(11):ytac440. PubMed ID: 36415685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients.
    Gallone G; Armeni P; Verheye S; Agostoni P; Timmers L; Campo G; Ielasi A; Sgura F; Tarantini G; Rosseel L; Zivelonghi C; Leenders G; Stella P; Tebaldi M; Tespili M; D'Amico G; Baldetti L; Ponticelli F; Colombo A; Giannini F
    Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):32-40. PubMed ID: 31124556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter treatment for refractory angina with the Coronary Sinus Reducer.
    Konigstein M; Meyten N; Verheye S; Schwartz M; Banai S
    EuroIntervention; 2014 Feb; 9(10):1158-64. PubMed ID: 24561732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study.
    Konigstein M; Ponticelli F; Zivelonghi C; Merdler I; Revivo M; Verheye S; Giannini F; Banai S
    Clin Cardiol; 2021 Mar; 44(3):424-428. PubMed ID: 33605473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method to interpret early phase trials shows how the narrowing of the coronary sinus concordantly improves symptoms, functional status and quality of life in refractory angina.
    Jolicoeur EM; Verheye S; Henry TD; Joseph L; Doucet S; White CJ; Edelman E; Banai S
    Heart; 2021 Jan; 107(1):41-46. PubMed ID: 32719097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of Coronary Sinus Reducer implantation at 2-year follow-up.
    Ponticelli F; Tzanis G; Gallone G; Baldetti L; Mangieri A; Colombo A; Giannini F
    Int J Cardiol; 2019 Oct; 292():87-90. PubMed ID: 31176523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double Reducer implantation in the coronary venous system for treatment of refractory angina: a case report.
    Picchi A; Misuraca L; Calabria P; Limbruno U
    Eur Heart J Case Rep; 2022 Jun; 6(6):ytac210. PubMed ID: 35673278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris.
    Tzanis G; Palmisano A; Gallone G; Ponticelli F; Baldetti L; Esposito A; Colombo A; Giannini F
    Catheter Cardiovasc Interv; 2020 May; 95(6):1104-1108. PubMed ID: 31373415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Innovative therapies for the treatment of refractory angina: the Reducer, a percutaneous device to narrow the coronary sinus].
    Benedetto D; Abawi M; Stella PR; Nijhoff F; Agostoni P
    G Ital Cardiol (Rome); 2015 Nov; 16(11):625-9. PubMed ID: 26571476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coronary sinus reducer: clinical evidence and technical aspects.
    Giannini F; Aurelio A; Jabbour RJ; Ferri L; Colombo A; Latib A
    Expert Rev Cardiovasc Ther; 2017 Jan; 15(1):47-58. PubMed ID: 27935738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.